Papers

2

Total Citations

52

H-Index

2

About

Dr. J. Louis Hinshaw is a pioneering researcher in interventional oncology, with a primary focus on non-invasive, image-guided ablation therapies. His work centers on the development and preclinical validation of histotripsy—a novel, non-thermal ultrasound technology that mechanically fractionates tissue—and its integration with robotic assistance and advanced imaging. Dr. Hinshaw’s major contributions include demonstrating the feasibility and safety of robotically-assisted sonic therapy for renal ablation, as detailed in his highly cited 2019 study (47 citations) using a live porcine model. He has also advanced the precision of this technique by evaluating the targeting accuracy of cone beam CT (CBCT) guided histotripsy in an *in vivo* porcine liver model (2025), establishing a critical workflow for clinical translation. By calibrating a robotic histotripsy arm with a C-arm CBCT system, his work directly addresses the challenge of real-time targeting in moving organs. With cumulative citations exceeding 50, Dr. Hinshaw’s research is foundational for bringing histotripsy from the lab to the clinic, offering a promising alternative to invasive surgery for solid tumors.

Research Focus

Key Achievements

2
H-Index
2
Papers
52
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Robotically-Assisted Sonic Therapy for Renal Ablation in a Live Porcine Model: Initial Preclinical Results
47 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Highland Community College - Illinois, University of Wisconsin–Madison

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago